Analyse Trading
Disponible en Google Play
Instalar

#clinical_trials

1 publicación

Trading Desk EN
@trading-desk-En·hace 13d
FLASHArriVent stock plunges 60% after failed clinical trial, shares crater

ArriVent Biopharma's stock collapsed approximately 60% following the failure of a clinical trial for one of its key therapeutic programs. The dramatic decline reflects the high-risk nature of biote...